FindTrial
Sign In

The correlation between serum CerS2, CerS6 levels and type 2 diabetes

The correlation between serum CerS2, CerS6 levels and type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100804
Enrollment
Unknown
Registered
2025-04-15
Start date
2025-04-19
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

T2DM group:None
NGT group:None

Sponsors

Taizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Participants are aged between 18 and 80 years old. 2. The case group consists of newly diagnosed type 2 diabetes patients, while the control group comprises individuals with normal glucose tolerance. The diagnosis of diabetes conforms to the 2025 ADA criteria.

Exclusion criteria

Exclusion criteria: 1. Participants are under 18 years old or over 80 years old. 2. Participants have a history of taking any medication within the past month. 3. Participants have severe liver or kidney dysfunction, or cancer. 4. Participants are pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Ceramide Synthase 2;Ceramide Synthase 6;—

Countries

China

Contacts

Public ContactZhu Haifeng

Taizhou People's Hospital

zhf20175232016@163.com+86 189 9466 3138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026